• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病前期患者胰岛素抵抗、超敏C反应蛋白、体脂与血清骨保护素/核因子κB受体活化因子配体之间的关系

Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients.

作者信息

Bilgir Oktay, Yavuz Mehmet, Bilgir Ferda, Akan Ozden Y, Bayindir Aslı G, Calan Mehmet, Bozkaya Giray, Yuksel Arif

机构信息

Department of Internal Medicine, Izmir Bozyaka Training and Research Hospital, Bozyaka, Izmir, Turkey -

Department of Internal Medicine, Izmir Bozyaka Training and Research Hospital, Bozyaka, Izmir, Turkey.

出版信息

Minerva Endocrinol. 2018 Mar;43(1):19-26. doi: 10.23736/S0391-1977.17.02544-5. Epub 2017 Jan 31.

DOI:10.23736/S0391-1977.17.02544-5
PMID:28146138
Abstract

BACKGROUND

Receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPN) are soluble members of the tumor necrosis factor superfamily. Growing evidence suggest that there is link between inflammation, insulin resistance and OPG, soluble RANKL (sRANKL). We aimed to ascertain whether OPG and sRANKL levels are altered in prediabetic subjects and there is association between OPG/sRANKL and metabolic parameters.

METHODS

Forty prediabetic subjects and 40 age- and BMI-matched controls were recruited for this cross-sectional study. Circulating OPG, sRANKL were measured using ELISA. Anthropometric and metabolic parameters were also determined.

RESULTS

Circulating sRANKL (97.74±17.67 vs. 55.00±11.19 pg/mL, P=0.010) and OPG (261.54±74.55 vs. 159.23±52.91 pg/mL, P=0.020) levels were found to be significantly higher in diabetic subjects compared with control subjects. There was a positive correlation between sRANKL and OPG. sRANKL also positively correlated with BMI, insulin resistance marker HOMA-IR, inflammatory marker hs-CRP. Logistic regression analyses revealed that the odds ratio was increased for prediabetes in subjects with having elevated sRANKL levels.

CONCLUSIONS

Increased sRANKL and OPG levels were associated with prediabetic subjects. sRANKL and OPG may play a role in the pathogenesis of diabetes as well as metabolic disturbance.

摘要

背景

核因子κB受体激活剂配体(RANKL)和骨保护素(OPG)是肿瘤坏死因子超家族的可溶性成员。越来越多的证据表明,炎症、胰岛素抵抗与OPG、可溶性RANKL(sRANKL)之间存在联系。我们旨在确定糖尿病前期患者的OPG和sRANKL水平是否发生改变,以及OPG/sRANKL与代谢参数之间是否存在关联。

方法

本横断面研究招募了40名糖尿病前期患者和40名年龄及体重指数匹配的对照者。采用酶联免疫吸附测定法检测循环中的OPG、sRANKL。还测定了人体测量和代谢参数。

结果

发现糖尿病前期患者的循环sRANKL水平(97.74±17.67 vs. 55.00±11.19 pg/mL,P = 0.010)和OPG水平(261.54±74.55 vs. 159.23±52.91 pg/mL,P = 0.020)显著高于对照者。sRANKL与OPG呈正相关。sRANKL还与体重指数、胰岛素抵抗标志物HOMA-IR、炎症标志物hs-CRP呈正相关。逻辑回归分析显示,sRANKL水平升高的受试者患糖尿病前期的比值比增加。

结论

sRANKL和OPG水平升高与糖尿病前期患者相关。sRANKL和OPG可能在糖尿病发病机制以及代谢紊乱中起作用。

相似文献

1
Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients.糖尿病前期患者胰岛素抵抗、超敏C反应蛋白、体脂与血清骨保护素/核因子κB受体活化因子配体之间的关系
Minerva Endocrinol. 2018 Mar;43(1):19-26. doi: 10.23736/S0391-1977.17.02544-5. Epub 2017 Jan 31.
2
Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis.系统性硬化症中的循环骨保护素和可溶性核因子κB受体活化因子配体
J Rheumatol. 2008 Nov;35(11):2206-13. doi: 10.3899/jrheum.080192. Epub 2008 Oct 1.
3
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.多囊卵巢综合征患者循环骨保护素和核因子κB 配体可溶性受体激活物:与胰岛素抵抗和血管内皮功能障碍的关系。
Eur J Endocrinol. 2011 Jan;164(1):61-8. doi: 10.1530/EJE-10-0720. Epub 2010 Oct 25.
4
Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women.绝经后肥胖女性体内的特定脂肪组织激素、骨代谢、骨保护素及核因子-κB受体活化因子配体
Endokrynol Pol. 2014;65(6):438-48. doi: 10.5603/EP.2014.0061.
5
Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.血清核因子-κB 受体激活剂配体(RANKL)水平可预测接受根治性前列腺切除术患者的生化复发。
BJU Int. 2014 Jan;113(1):152-9. doi: 10.1111/j.1464-410X.2012.11759.x. Epub 2013 Jan 29.
6
RANKL/RANK/OPG system and bone status in females with anorexia nervosa.神经性厌食女性的 RANKL/RANK/OPG 系统与骨状态。
Bone. 2012 Jan;50(1):156-60. doi: 10.1016/j.bone.2011.09.054. Epub 2011 Oct 6.
7
High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增多症中可溶性CD154、白细胞介素-2受体、核因子κB受体活化因子配体及骨保护素的血清高值。
Pediatr Blood Cancer. 2006 Aug;47(2):194-9. doi: 10.1002/pbc.20595.
8
sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients.一组男性和女性血液透析患者中的sRANKL/骨保护素复合物及生化标志物
J Endocrinol Invest. 2007 Oct;30(9):762-6. doi: 10.1007/BF03350814.
9
Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.上埃及依赖输血的小儿重型纯合子β地中海贫血的铁螯合疗法:对血清L-肉碱/游离脂肪酸、骨保护素/核因子κB受体激活因子配体系统及骨密度的影响
J Pediatr Hematol Oncol. 2010 May;32(4):267-73. doi: 10.1097/MPH.0b013e3181d419d6.
10
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.测量老年女性骨代谢中核因子-κB 受体活化因子配体和骨保护素的可溶性受体的意义
Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22.

引用本文的文献

1
Correlation of the differential expressions of RANK, RANKL, and OPG with obesity in the elderly population in Xinjiang.新疆老年人群中RANK、RANKL和OPG的差异表达与肥胖的相关性
Open Med (Wars). 2025 Aug 7;20(1):20251196. doi: 10.1515/med-2025-1196. eCollection 2025.
2
Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT.地诺单抗对接受雌二醇抑制治疗的绝经前乳腺癌女性的心脏代谢影响:随机对照试验
J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1857-e1866. doi: 10.1210/clinem/dgae003.
3
Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease.
肥胖、2 型糖尿病和非酒精性脂肪性肝病中的护骨素/核因子-κB 配体/核因子-κB 受体激活剂轴。
Curr Obes Rep. 2023 Jun;12(2):147-162. doi: 10.1007/s13679-023-00505-4. Epub 2023 May 19.
4
Osteometabolism: Metabolic Alterations in Bone Pathologies.骨代谢:骨骼病理学中的代谢改变。
Cells. 2022 Dec 6;11(23):3943. doi: 10.3390/cells11233943.
5
Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children.超重和肥胖儿童可溶性核因子-κB 受体激活剂配体(sRANKL)水平降低。
Front Endocrinol (Lausanne). 2022 Aug 19;13:963467. doi: 10.3389/fendo.2022.963467. eCollection 2022.
6
Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification.骨保护素/核因子κB受体激活剂配体参与牙周炎促进的血管钙化。
Exp Ther Med. 2022 Jun 14;24(2):512. doi: 10.3892/etm.2022.11439. eCollection 2022 Aug.
7
Inverse Regulation of Serum Osteoprotegerin and B-Type Natriuretic Peptide Concentrations by Free Fatty Acids Elevation in Young Healthy Humans.血清游离脂肪酸水平升高对年轻健康人体骨保护素和 B 型利钠肽浓度的反向调节作用
Nutrients. 2022 Feb 17;14(4):837. doi: 10.3390/nu14040837.
8
Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients.血清可溶性核因子κB受体活化因子配体(sRANKL)水平低与代谢失调相关,并可预测危重症患者的长期死亡率。
Diagnostics (Basel). 2021 Dec 28;12(1):62. doi: 10.3390/diagnostics12010062.
9
Endocrine role of bone in the regulation of energy metabolism.骨骼在能量代谢调节中的内分泌作用。
Bone Res. 2021 May 20;9(1):25. doi: 10.1038/s41413-021-00142-4.
10
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease.骨保护素/核因子-κB 受体激活剂/核因子-κB 受体激活剂配体轴在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2018 May 21;24(19):2073-2082. doi: 10.3748/wjg.v24.i19.2073.